BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 16541117)

  • 1. Gene transfer of RANTES and MCP-1 chemokine antagonists prolongs cardiac allograft survival.
    Fleury S; Li J; Simeoni E; Fiorini E; von Segesser LK; Kappenberger L; Vassalli G
    Gene Ther; 2006 Jul; 13(14):1104-9. PubMed ID: 16541117
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lentiviral gene transfer of the chemokine antagonist RANTES 9-68 prolongs heart graft survival.
    Vassalli G; Simeoni E; Li JP; Fleury S
    Transplantation; 2006 Jan; 81(2):240-6. PubMed ID: 16436968
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene transfer of soluble interleukin-17 receptor prolongs cardiac allograft survival in a rat model.
    Li J; Simeoni E; Fleury S; Dudler J; Fiorini E; Kappenberger L; von Segesser LK; Vassalli G
    Eur J Cardiothorac Surg; 2006 May; 29(5):779-83. PubMed ID: 16520057
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of chemokine receptor CCR2 and CCR5 expression contributes to simvastatin-induced attenuation of cardiac allograft vasculopathy.
    Yin R; Zhu J; Shao H; Cheng X; Feng X; Li Z; Jing H
    J Heart Lung Transplant; 2007 May; 26(5):485-93. PubMed ID: 17449418
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined blockade of the chemokine receptors CCR1 and CCR5 attenuates chronic rejection.
    Yun JJ; Whiting D; Fischbein MP; Banerji A; Irie Y; Stein D; Fishbein MC; Proudfoot AE; Laks H; Berliner JA; Ardehali A
    Circulation; 2004 Feb; 109(7):932-7. PubMed ID: 14757698
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene transfer of interleukin-18-binding protein attenuates cardiac allograft rejection.
    Dudler J; Simeoni E; Fleury S; Li J; Pagnotta M; Pascual M; von Segesser LK; Vassalli G
    Transpl Int; 2007 May; 20(5):460-6. PubMed ID: 17313449
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human monocyte-derived dendritic cells expressing both chemotactic cytokines IL-8, MCP-1, RANTES and their receptors, and their selective migration to these chemokines.
    Zhu K; Shen Q; Ulrich M; Zheng M
    Chin Med J (Engl); 2000 Dec; 113(12):1124-8. PubMed ID: 11776150
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of RANTES in experimental cardiac allograft rejection.
    Mulligan MS; McDuffie JE; Shanley TP; Guo RF; Vidya Sarma J; Warner RL; Ward PA
    Exp Mol Pathol; 2000 Dec; 69(3):167-74. PubMed ID: 11115358
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Direct anti-inflammatory mechanisms contribute to attenuation of experimental allograft arteriosclerosis by statins.
    Shimizu K; Aikawa M; Takayama K; Libby P; Mitchell RN
    Circulation; 2003 Oct; 108(17):2113-20. PubMed ID: 14517172
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gene transfer of virally encoded chemokine antagonists vMIP-II and MC148 prolongs cardiac allograft survival and inhibits donor-specific immunity.
    DeBruyne LA; Li K; Bishop DK; Bromberg JS
    Gene Ther; 2000 Apr; 7(7):575-82. PubMed ID: 10819572
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene transfer of the S24F regulated on activation normal T-cell expressed and secreted-chemokine ligand 5 variant attenuates cardiac allograft rejection.
    Sun Y; Feng J; Shi J; Lu X; Xie A; Chen Y; Dong N
    Transplantation; 2014 Jun; 97(12):1233-9. PubMed ID: 24825519
    [TBL] [Abstract][Full Text] [Related]  

  • 12. KRP-203, a novel synthetic immunosuppressant, prolongs graft survival and attenuates chronic rejection in rat skin and heart allografts.
    Shimizu H; Takahashi M; Kaneko T; Murakami T; Hakamata Y; Kudou S; Kishi T; Fukuchi K; Iwanami S; Kuriyama K; Yasue T; Enosawa S; Matsumoto K; Takeyoshi I; Morishita Y; Kobayashi E
    Circulation; 2005 Jan; 111(2):222-9. PubMed ID: 15642767
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel immunomodulator KRP-203 combined with cyclosporine prolonged graft survival and abrogated transplant vasculopathy in rat heart allografts.
    Takahashi M; Shimizu H; Murakami T; Enosawa S; Suzuki C; Takeno Y; Hakamata Y; Kudou S; Izawa S; Yasue T; Kobayashi E
    Transplant Proc; 2005; 37(1):143-5. PubMed ID: 15808575
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monocyte chemoattractant protein-1 and RANTES are chemotactic for graft infiltrating lymphocytes during acute lung allograft rejection.
    Sekine Y; Yasufuku K; Heidler KM; Cummings OW; Van Rooijen N; Fujisawa T; Brown J; Wilkes DS
    Am J Respir Cell Mol Biol; 2000 Dec; 23(6):719-26. PubMed ID: 11104723
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Critical role for monocyte chemoattractant protein-1 and macrophage inflammatory protein-1alpha in induction of experimental autoimmune myocarditis and effective anti-monocyte chemoattractant protein-1 gene therapy.
    Göser S; Ottl R; Brodner A; Dengler TJ; Torzewski J; Egashira K; Rose NR; Katus HA; Kaya Z
    Circulation; 2005 Nov; 112(22):3400-7. PubMed ID: 16316965
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coxiella burnetii stimulates production of RANTES and MCP-1 by mononuclear cells: modulation by adhesion to endothelial cells and its implication in Q fever.
    Meghari S; Desnues B; Capo C; Grau GE; Raoult D; Mege JL
    Eur Cytokine Netw; 2006 Dec; 17(4):253-9. PubMed ID: 17353158
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipid-mediated gene transfer of viral IL-10 prolongs vascularized cardiac allograft survival by inhibiting donor-specific cellular and humoral immune responses.
    DeBruyne LA; Li K; Chan SY; Qin L; Bishop DK; Bromberg JS
    Gene Ther; 1998 Aug; 5(8):1079-87. PubMed ID: 10326031
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The chemokine and chemokine receptor profile of infiltrating cells in the wall of arteries with cardiac allograft vasculopathy is indicative of a memory T-helper 1 response.
    van Loosdregt J; van Oosterhout MF; Bruggink AH; van Wichen DF; van Kuik J; de Koning E; Baan CC; de Jonge N; Gmelig-Meyling FH; de Weger RA
    Circulation; 2006 Oct; 114(15):1599-607. PubMed ID: 17015796
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunity to islet grafts transduced with adenovirus vectors does not inhibit long-term islet function.
    Cheng J; Sun J; Sung RS
    Transpl Immunol; 2009 May; 21(1):33-42. PubMed ID: 19224710
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antimonocyte chemoattractant protein-1 gene therapy attenuates graft vasculopathy.
    Saiura A; Sata M; Hiasa K; Kitamoto S; Washida M; Egashira K; Nagai R; Makuuchi M
    Arterioscler Thromb Vasc Biol; 2004 Oct; 24(10):1886-90. PubMed ID: 15284091
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.